References
- BELL, J. A. and TARBIT, M. H., 1992, Comment: Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry. Xenobiotica, 22, 735–742.
- BEUDRY, F., LEBLANC, J. C., COUTU, M. and BROWN, N. K., 1998, In vivo pharmacokinetic screening in cassette dosing experiments, the use of on-line Prospekt liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry technology in drug discovery. Rapid Communications in Mass Spectrometry, 12, 1216–1222.
- CARTER, B. L., NOYES, M. A., DEMMIER, R. W., BERNETTE, D. J. and PIEPER, J. A., 1996, Pharmacokinetics of verapirnil and its metabolites in elderly and young volunteers. Journal of Applied Therapeutics, 1, 85–91.
- CASE, D. E., 1981, The state of the art: a commentary on the current practice of metabolism and pharmacokinetic studies in the pharmaceutical industry. Xenobiotica, 11, 803–814.
- COLE, R. O., LAWS, K. A., HILLER, D. L., KIPLINGER, J. P. and WARE, R. S., 1998, Reduced dimension HPLC columns as a preclinical tool for rapid separations in drug discovery. American Laboratory, 30, 15–20.
- DIMASI, J., 1995, Success rates for new drugs entering clinical testing in the United States. Clinical Pharmacology and Therapeutics, 58, 1–14.
- LIPINSKI, C. A., LOMBARDO, F., DOMINY, B. W. and FEENEY, P. J., 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
- PRENTIS, R. A., Lis, Y. and WALKER, S. R., 1988, Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). British Journal of Clinical Pharmacology, 25, 387–396.
- ROY, M. L., DUMAINE, R. and BROWN, A. M., 1996, HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation, 94, 817–823.
- SMITH, D. A. and VAN DE WATERBEEMD, H., 1999, Pharmacokinetics and metabolism in early drug discovery. Current Opinion in Chemical Biology, 3, 373–378.
- WALDEGGERS, S., NIEMEYER, G., MORIKE, K. and WAGNER, C. A., 1999, Effect of verapimil enatiomers and metabolites on cardiac K+ channels expressed in Zenous. Cell Physiology and Biochemistry, 9, 81–89.
- WILLIAMS, R. T., 1947, Detoxication Mechanisms: The Metabolism and Detoxication of Drugs, Toxic Substances and Other Organic Compounds (London: Chapman & Hall).
- TANII, H. and HASHIMOTO, K., 1982, Structure-toxicity relationship of acrylates and methacrylates. Toxicology Letters, 11, 125–129.
- VERHAAR, H. J. M., MORRONI, J. S., REARDON, K. F., HAYS, S. M., GAYER, D. P., JR., CARPENTER, R. L. and YANG, R. S. H., 1997, A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling. Environmental Health Perspectives, 105 (suppl. 1), 179–195.
- VODICKA, P., GUT, I. and FRANTIK, E., 1990, Effects of inhaled acrylic acid derivates in rats. Toxicology, 65, 209–221.
- YANG, R. S., THOMAS, R. S., GUSTAFSON, D. L., CAMPAIN, J., BENJAMIN, S. A., VERHAAR, H. J. and MUMTAZ, M. M., 1998, Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. Environmental Health Perspectives, 106 (suppl. 6), 1385–1393.